MedTrace Logo

Intermittent Antimalaria Treatment With SP in African Children

NCT00168948 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1200

Last updated 2005-11-02

No results posted yet for this study

Summary

\- intermittent preventive treatment with SP in children to evaluate efficacy and safety of this drug combination in children in northern Ghana

Conditions

Interventions

DRUG

Sulfadoxin (12.5) Pyrimethamine (250 mg)

Sponsors & Collaborators

  • Deutscher Akademischer Austausch Dienst

    collaborator OTHER

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Frank Mockenhaupt, PhD · Charite University-Medicine, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
4 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-03-31
Completion
2005-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168948 on ClinicalTrials.gov